BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 19519732)

  • 1. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24-h pH monitoring is necessary to assess acid reflux suppression in patients with Barrett's oesophagus undergoing treatment with proton pump inhibitors.
    Ortiz A; Martínez de Haro LF; Parrilla P; Molina J; Bermejo J; Munitiz V
    Br J Surg; 1999 Nov; 86(11):1472-4. PubMed ID: 10583299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
    Blonski W; Vela MF; Castell DO
    J Clin Gastroenterol; 2009 Oct; 43(9):816-20. PubMed ID: 19398927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor influence on reflux in Barrett's oesophagus.
    Smythe A; Troy GP; Ackroyd R; Bird NC
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):881-7. PubMed ID: 18794602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
    Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
    Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
    Frazzoni M; Manno M; De Micheli E; Savarino V
    Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus.
    Wani S; Sampliner RE; Weston AP; Mathur S; Hall M; Higbee A; Sharma P
    Aliment Pharmacol Ther; 2005 Oct; 22(7):627-33. PubMed ID: 16181302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.
    Loughney T; Maydonovitch CL; Wong RK
    Am J Gastroenterol; 1998 Jun; 93(6):916-9. PubMed ID: 9647018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy.
    Gerson LB; Mitra S; Bleker WF; Yeung P
    Aliment Pharmacol Ther; 2012 Apr; 35(7):803-9. PubMed ID: 22356659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of esophageal manometry in the management of the patients with gastro-esophageal reflux disease and Barrett's esophagus].
    Hoară P; Bîrlă R; Gîndea C; Constantin A; Panaitescu G; Iordan N; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(4):407-12. PubMed ID: 18780613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study.
    Talaie R; Forootan M; Donboli K; Dadashzadeh N; Sadeghi A; Poorsaadat S; Moghimi B; Mohammad Alizadeh AH; Zali MR
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):11-5. PubMed ID: 19337627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can acid (pH) refluxes predict multichannel intraluminal impedance refluxes? A correlation study.
    Misra S
    J Gastroenterol Hepatol; 2010 Apr; 25(4):817-22. PubMed ID: 20492340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
    Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
    Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
    Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
    Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.